pamidronate has been researched along with Mast Cell Activation Disease in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Bone densitometry is particularly effective for early detection of patients at risk for fracture and is of practical interest since patients with osteoporosis can now be treated with Pamidronate." | 3.71 | [Bone evaluation in ten adults with cutaneous mastocytosis]. ( Armingaud, P; Benhamou, CL; Estève, E; Kerdraon, R; Lespessailles, E; Petavy-Catala, C; Zerkak, D, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laroche, M | 1 |
| Livideanu, C | 1 |
| Paul, C | 1 |
| Cantagrel, A | 1 |
| Marshall, A | 1 |
| Kavanagh, RT | 1 |
| Crisp, AJ | 1 |
| Brunel, V | 1 |
| Tadrist, Z | 1 |
| Cailleres, S | 1 |
| Allegre, T | 1 |
| Blanc, AP | 1 |
| Brumsen, C | 1 |
| Hamdy, NA | 1 |
| Papapoulos, SE | 1 |
| Armingaud, P | 1 |
| Zerkak, D | 1 |
| Lespessailles, E | 1 |
| Petavy-Catala, C | 1 |
| Kerdraon, R | 1 |
| Benhamou, CL | 1 |
| Estève, E | 1 |
5 other studies available for pamidronate and Mast Cell Activation Disease
| Article | Year |
|---|---|
Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combinati | 2011 |
The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis.
Topics: Adult; Bone Density; Diphosphonates; Female; Humans; Lumbar Vertebrae; Male; Mastocytosis; Middle Ag | 1997 |
[Interferon alpha and pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis].
Topics: Anti-Inflammatory Agents; Bone Density; Diphosphonates; Humans; Interferon-alpha; Male; Mastocytosis | 1998 |
Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy.
Topics: Bone Density; Diphosphonates; Humans; Male; Mast Cells; Mastocytosis; Middle Aged; Osteoporosis; Pam | 2002 |
[Bone evaluation in ten adults with cutaneous mastocytosis].
Topics: Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Bone Marrow | 2002 |